Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 307 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Asia-Pacific | 307 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 12,440 |
| France | 1,867 |
| China | 1,612 |
| Germany | 1,389 |
| United Kingdom | 1,087 |
| Spain | 1,076 |
| Italy | 1,044 |
| Canada | 932 |
Trial sites
307 sites. Sites with a public page link to it on Pharma Observatory.
-
Novartis Investigative Site 49 trials
-
Research Site 48 trials
-
Research Site 48 trials
-
Research Site 47 trials
-
Novartis Investigative Site 46 trials
-
Novartis Investigative Site 46 trials
-
Tata Memorial Hospital 46 trials
-
Research Site 45 trials
-
Novo Nordisk Investigational Site 43 trials
-
Nirmal Hospital Pvt. Ltd. 42 trials
-
PGIDS 42 trials
-
Pfizer Investigational Site 42 trials
-
Novo Nordisk Investigational Site 41 trials
-
Research Site 41 trials
-
GSK Investigational Site 40 trials
-
Novartis Investigative Site 40 trials
-
Novo Nordisk Investigational Site 39 trials
-
PGIMER 39 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.